Abstract:Diabetes mellitus type 1 (DM1) is an autoimmune disease that gradually destroys insulin-producing beta-cells. We have previously reported that mucosal administration of fusion protein of HSP65 with tandem repeats of P277 (HSP65-6P277) can reduce the onset of DM1 in non-obese diabetic (NOD) mice. To deliver large amounts of the fusion protein and to enhance long-term immune tolerance effects, in the present study, we investigated the efficacy of using orally administrated L. lactis expressing HSP65-6P277 to reduce the incidence of DM1 in NOD mice. L. lactis strain NZ9000 was engineered to express HSP65-6P277 either constitutively or by nisin induction. After immunization via gavage with the recombinant L. lactis strains to groups of 4-week old female NOD mice for 36 weeks, we observed that oral administration of recombinant L. Lactis resulted in the prevention of hyperglycemia, improved glucose tolerance and reduced insulitis. Immunologic analysis showed that treatment with recombinant L. lactis induced HSP65- and P277- specific T cell immuno-tolerance, as well as antigen-specific proliferation of splenocytes. The results revealed that the DM1-preventing function was in part caused by a reduction in the pro-inflammatory cytokine IFN-γ and an increase in the anti-inflammatory cytokine IL-10. Orally administered recombinant L. lactis delivering HSP65-6P277 may be an effective therapeutic approach in preventing DM1.

Study on the Hypoglycemic Mechanism of the Fusion Protein HSP65-6×P277 in NOD Mice

HSP65 serves as an immunogenic carrier for a diabetogenic peptide P277 inducing anti-inflammatory immune response in NOD mice by nasal administration.

Oral Administration of Recombinant Lactococcus Lactis Expressing Hsp65 and Tandemly Repeated P277 Reduces the Incidence of Type I Diabetes in Non-Obese Diabetic Mice

Vaccination of non-obese diabetic mice with a fragment of peptide P277 attenuates insulin-dependent diabetes mellitus

[Improved Efficacy of P277 Fused to Heat Shock Protein 65 of Mycobacterium Tuberculosis Against Diabetes in Nonobese Diabetic Mice].

Intranasal Vaccination with P277 Tandem Repeat Sequences Carried by Hsp65 Prevented Type 1 Diabetes in NOD Mice

Prevention of Strain Fermentation in Hirsutella Sinensis on Type 1 Diabetes of Non-Obese Diabetic Mice

Oral Delivery of Single-Chain Insulin (SCI-59) Analog by Bacterium-Like Particles (blps) Induces Oral Tolerance and Prevents Autoimmune Diabetes in NOD Mice.

Enhanced Immunogenicity of Peptide P277 by Heat Shock Protein Hsp65 Vector Carrying Tandem Repeats of P277 to Prevent Type 1 Diabetes in Nod Mice

[Intranasal Vaccination with Mycobacterial 65-Kd Heat-Shock Protein Can Prevent Insulitis and Diabetes in Non-Obese Diabetic Mice].

Oral Administration of Lactococcus Lactis-Expressing Heat Shock Protein 65 and Tandemly Repeated IA2P2 Prevents Type 1 Diabetes in NOD Mice.

Effct of Heat Shock Protein 65 of Mycobacterium Tuberculosis on Prevention of Diabetes in Nonobese Diabetic Mice

Interleukin‐17‐producing Γδ+ T Cells Protect NOD Mice from Type 1 Diabetes Through a Mechanism Involving Transforming Growth Factor‐β

Beyond Knockout: A Novel Homodimerization-Targeting MyD88 Inhibitor Prevents and Cures Type 1 Diabetes in NOD Mice

A Th1-recognized peptide P277, when tandemly repeated, enhances a Th2 immune response toward effective vaccines against autoimmune diabetes in nonobese diabetic mice.

Oral administration of CTB insulin B chain produced in silkworm delays the diabetes development in NOD mice

GAD-IgG-inducing CD4+Foxp3+Treg Cells Suppressing Diabetes Are Involved in the Increasing Ratio of CD80+:CD86+ Cells in NOD Mice

HSPB8 Overexpression Ameliorates Cognitive Impairment in Diabetic Mice via Inhibiting NLRP3 Inflammation Activation

Protective Response Against Type 1 Diabetes in Nonobese Diabetic Mice after Coimmunization with Insulin and Dna Encoding Proinsulin

Histopathologic study on pancreatic islets of nonobese diabetic mice orally administrated by insulin

[Study on Total Glucosides of Peony Preventing Non-Obese Diabetic Mice from Sialoadenitis].